Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 24, 2012
Structural basis for telmisartan-mediated partial activation of PPAR gammaYasushi Amano, Tomohiko Yamaguchi, Kazuki Ohno, et al.
Current Computer-Aided Drug Design|September 10, 2013
Accelerating quantum chemistry calculations with graphical processing units - toward in high-density (HD) silico drug discoveryYohsuke Hagiwara, Kazuki Ohno, Masaya Orita, et al.
Molecular Genetics and Metabolism Reports|November 30, 2016
Plasma mutant α-galactosidase A protein and globotriaosylsphingosine level in Fabry diseaseTakahiro Tsukimura, Sachie Nakano, Tadayasu Togawa, et al.
Expert Opinion on Drug Discovery|May 21, 2013
Molecular modeling of vasopressin receptor and in silico screening of V1b receptor antagonistsYohsuke Hagiwara, Kazuki Ohno, Masazumi Kamohara, et al.
Journal of Human Genetics|August 1, 2009
Structural bases of GM1 gangliosidosis and Morquio B diseaseMizuki Morita, Seiji Saito, Kazuyoshi Ikeda, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 14, 2011
Therapeutic potential of intracerebroventricular replacement of modified human β-hexosaminidase B for GM2 gangliosidosisKazuhiko Matsuoka, Tomomi Tamura, Daisuke Tsuji, et al.
Molecular Genetics and Metabolism Reports|November 3, 2018
Fabry disease in a Japanese population-molecular and biochemical characteristicsHitoshi Sakuraba, Takahiro Tsukimura, Tadayasu Togawa, et al.
Journal of Human Genetics|April 4, 2009
Structural modeling of mutant alpha-glucosidases resulting in a processing/transport defect in Pompe diseaseKanako Sugawara, Seiji Saito, Masakazu Sekijima, et al.
Journal of Human Genetics|June 26, 2015
Chaperone therapy for Krabbe disease: potential for late-onset GALC mutationsMohammad Arif Hossain, Katsumi Higaki, Seiji Saito, et al.
Pageof 6